News

Researchers from Massachusetts General Hospital and Brigham and Women’s Hospital have reprogrammed the tumor microenvironment of liver cancer using mRNA nanoparticles.

A new study has found that extracellular magnesium levels affect T-cell responses both in vitro and in vivo.

A study shows that triplatin is effective against triple negative breast cancer, the most aggressive form of breast cancer.

Researchers have received a grant to look at the relationship between obesity and breast cancer.

Researchers have demonstrated a new therapeutic way to block RAS, a protein that is frequently mutated in cancers.

According to research, culture environments of different cell types growing in culture vessels or Petri dishes vary significantly from each other and from conditions in the living body.

Researchers have developed a compound that may one day offer hope for pancreatic cancer treatment.

Drugs that are commonly used as the first line of treatment for colorectal cancer can cause cancer cells to oversecrete proteins known as mucins. The proteins form a physical barrier that prevents drugs from reaching their target.

A study has shown that immunosuppressed individuals can build up sufficient immunity against the SARS-CoV-2 virus after the third vaccination or “booster”.

A collaborative team of researchers has been able to shed light on these processes by which KRAS oncogenes drive tumor formation.